News

 

NEWS

Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator

Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator Accelerate Innovations in Life Science Osaka, Japan and San Carlos, CA (May 1, 2018) Nitto Denko Corporation (Head Office: Osaka City, President: Hideo Takasaki), a global materials company, and MBC BioLabs (Location: San Carlos, California, General Manager: Douglas Crawford), a life science incubator in the San [...]Read more

AMGEN and MBC BioLabs invite you to apply for the 2018 AMGEN Golden Ticket!

AMGEN and MBC BioLabs invite you to apply for the 2018 AMGEN Golden Ticket! Looking for a free year of lab space at San Francisco's premier life sciences incubator? Amgen can help! Amgen is awarding up to 2 Golden Tickets to high-potential and innovative life science and biotech startups that have the ability to impact patients’ lives. A Golden Ticket [...]Read more

Corning Sponsorship in San Carlos

Corning Sponsorship in San Carlos Corning is pleased to announce sponsorship of the new MBC BioLabs site at San Carlos with the placement of several brand new instruments! Corning is a trusted supplier to the healthcare and pharmaceutical industries since we introduced PYREX® glass in 1915. Today, We are a leader in lab products, cell culture solutions, bioprocess vessels, and [...]Read more

Indee Labs Secures Funding to Develop Unique Gene Therapy Manufacturing Technology in Australia

Indee Labs Secures Funding to Develop Unique Gene Therapy Manufacturing Technology in Australia Read Full Press Release Indee Labs will receive grant funding of nearly $1M from the Australian Government’s $35 million BioMedTech Horizons program. The project will see Indee Labs make a new generation of medicine, known as gene therapy, accessible to the masses. The impact of gene therapies [...]Read more

GraphWear Technologies Raises a $4.2M Series A

GraphWear Technologies Raises a $4.2M Series A Read Full Press Release GraphWear makes a graphene-based sensor technology that can provide biological information from sweat. Initially ideated to provide performance athletes with advanced information, the latest use case in the works for GraphWear is aimed at a needle-free glucose test, expected to hit the market three to four years down the [...]Read more

Congratulations to Asilomar Bio with their success and growth to their own space in Emeryville!

Congratulations to Asilomar Bio with their success and growth to their own space in Emeryville! A field of corn is one of the most complex systems in Nature. Individual plants are constantly sensing the environment and adjusting how to use the water and nutrients in the soil. Building on breakthrough discoveries in chemistry and plant science, we are developing products [...]Read more

MBC BioLabs Grand Opening in San Carlos

MBC BioLabs Grand Opening in San Carlos In just over four years, the MBC BioLabs Dogpatch site has been home to 102 companies, 45 of which are current residents. These companies have been wildly-successful – they have raised $1.8 billion. Our one significant challenge has been the limited amount of space. We receive 6-10 applications per month, but as we [...]Read more

Wild Type raises $3.5M to reinvent meat for the 21st century

Wild Type raises $3.5M to reinvent meat for the 21st century by Danny Crichton, March 29, 2018 Read article at Techcrunch Food security is one of the grand problems facing the planet this century. The UN has estimated that food supplies need to increase by 50 percent to cover the population growth expected over the coming decades, while climate change [...]Read more

ViewPoint Therapeutics Raises $35 Million in Series B Financing

ViewPoint Therapeutics Raises $35 Million in Series B FinancingProceeds will advance lead product candidate through clinical proof-of-concept studies in cataracts and presbyopia Series B led by The Rise Fund, a global impact fund SAN FRANCISCO, Calif., March 5, 2018 – ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, [...]Read more

We welcome ph PHARMA

We welcome ph PHARMA pH Pharma’s vision is to discover and develop distinctive and innovative healthcare technologies and therapies. Our therapeutic candidates in clinical development target glaucoma and metabolic syndromes. We are also focused on a pre-clinical program to discover novel oncology therapeutics. pH Pharma was founded in 2015 and is headquartered in Seoul, South Korea with a main Silicon Valley office in [...]Read more
Page 1 of 1112345...10...Last »

Upcoming Event

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter